← Eichor
Condition: Patients With Prostate Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Patients With Prostate Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Dar
Phase N/A · 1 location(s) · Bayer · NCT07672119ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerabl
Phase 3 · 95 location(s) · UNICANCER · NCT04916613Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Phase 1 · 7 location(s) · Novartis Pharmaceuticals · NCT07006727Transperineal Versus Transrectal Cognitive Fusion Prostate Biopsy
NA · 1 location(s) · Ankara Etlik City Hospital · NCT07710807Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-int
Phase 2 · 1 location(s) · Samsung Medical Center · NCT06461819Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer
EARLY_Phase 1 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07156045A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Phase 1 · 25 location(s) · Astellas Pharma Global Development, Inc. · NCT04729114A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Phase 3 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07241416Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal
Phase 2 · 3 location(s) · SMED Clinical Research · NCT07299292Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Pati
Phase 2 · 1 location(s) · Samsung Medical Center · NCT06461793At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
Phase 2 · 9 location(s) · Curasight · NCT06474806A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Phase 2 · 7 location(s) · Candel Therapeutics, Inc. · NCT07332000Clinical Evaluation of 177Lu-PSMA-VG01 Injection in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate
Phase 1 · 1 location(s) · VitsGen Therapeutics Inc. · NCT07660211Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
NA · 1 location(s) · Paul Viscuse · NCT06429813PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostat
Phase 2/Phase 3 · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07426055Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Pros
Phase N/A · 1 location(s) · Zhen Li · NCT06946771Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Phase 2 · 3 location(s) · Psyence Australia Pty Ltd · NCT07072728Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
NA · 1 location(s) · Hong Kong Sanatorium & Hospital · NCT07130682Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy
Phase N/A · 3 location(s) · Santa Chiara Hospital · NCT06473259XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 2 · 1 location(s) · University of Utah · NCT06568562Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07468903Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Pros
Phase 2 · 15 location(s) · Instituto de Investigación en Oncología Radioterápica - Fund · NCT07717268177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT07219147A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06826768Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI
Phase 2 · 3 location(s) · Ain Shams University · NCT07693075A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Phase 1 · 10 location(s) · Dren Bio · NCT06999187Hong Kong Prostate Cancer Study Group Database
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT03344835Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Phase 1/Phase 2 · 1 location(s) · Charles Drew University of Medicine and Science · NCT06615752Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Phase 1 · 39 location(s) · SystImmune Inc. · NCT05983432
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.